Vanguard Personalized Indexing Management LLC Acquires 21,544 Shares of CVS Health Corporation $CVS

Key Points

• Vanguard Personalized Indexing Management LLC increased its stake in CVS Health Corporation by 16.6%, acquiring an additional 21,544 shares in the second quarter, bringing its total ownership to 151,240 shares valued at approximately $10.43 million.
• CVS Health's quarterly earnings report indicated a significant revenue increase of 8.4% from the previous year, with earnings per share (EPS) beating estimates at $1.81.
• The company announced a quarterly dividend of $0.665 to be paid on November 3rd, representing an annualized yield of 3.4%.

Vanguard Personalized Indexing Management LLC grew its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 16.6% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 151,240 shares of the pharmacy operator's stock after purchasing an additional 21,544 shares during the quarter. Vanguard Personalized Indexing Management LLC's holdings in CVS Health were worth $10,434,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the company. Concurrent Investment Advisors LLC raised its holdings in CVS Health by 20.6% during the 2nd quarter. Concurrent Investment Advisors LLC now owns 16,193 shares of the pharmacy operator's stock worth $1,117,000 after purchasing an additional 2,771 shares during the last quarter. Aberdeen Group plc raised its holdings in CVS Health by 3.0% during the 2nd quarter. Aberdeen Group plc now owns 1,178,288 shares of the pharmacy operator's stock worth $81,278,000 after purchasing an additional 34,810 shares during the last quarter. PDS Planning Inc raised its holdings in CVS Health by 10.6% during the 2nd quarter. PDS Planning Inc now owns 4,779 shares of the pharmacy operator's stock worth $330,000 after purchasing an additional 459 shares during the last quarter. Commerzbank Aktiengesellschaft FI raised its holdings in CVS Health by 19.9% during the 2nd quarter. Commerzbank Aktiengesellschaft FI now owns 64,971 shares of the pharmacy operator's stock worth $4,482,000 after purchasing an additional 10,795 shares during the last quarter. Finally, Argyle Capital Management LLC raised its holdings in CVS Health by 0.7% during the 2nd quarter. Argyle Capital Management LLC now owns 30,417 shares of the pharmacy operator's stock worth $2,098,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Stock Performance

NYSE CVS opened at $77.89 on Monday. The company has a fifty day simple moving average of $72.28 and a 200 day simple moving average of $67.67. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $79.20. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74. The company has a market cap of $98.79 billion, a P/E ratio of 21.76, a PEG ratio of 0.86 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. During the same quarter last year, the firm posted $1.83 EPS. CVS Health's revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.4%. CVS Health's dividend payout ratio (DPR) is presently 74.30%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CVS. Bernstein Bank lowered their price target on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a report on Wednesday, July 16th. UBS Group raised shares of CVS Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $67.00 to $79.00 in a research report on Monday, August 18th. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a research report on Sunday, September 21st. Wolfe Research raised their price objective on shares of CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a research report on Monday, September 22nd. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of CVS Health in a research report on Saturday, September 27th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the company's stock. Based on data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus target price of $79.80.

Insider Transactions at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of CVS Health stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company's stock, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.